80_FR_27424 80 FR 27332 - National Institute on Drug Abuse; Notice of Closed Meetings

80 FR 27332 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 92 (May 13, 2015)

Page Range27332-27333
FR Document2015-11477

Federal Register, Volume 80 Issue 92 (Wednesday, May 13, 2015) 
[Federal Register Volume 80, Number 92 (Wednesday, May 13, 2015)]
[Notices]
[Pages 27332-27333]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-11477]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel NIH Pathway to Independence Award (K99/R00).
    Date: June 4, 2015.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
4238, MSC 9550, Bethesda, MD 20892, 301-402-6020, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel NIH Summer Research Experience Programs (R25).
    Date: June 4, 2015.
    Time: 12:00 p.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).

[[Page 27333]]

    Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
4238, MSC 9550, Bethesda, MD 20892, 301-402-6020, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Exploratory Studies of Smoking Cessation 
Interventions for People with Schizophrenia (R21/R33).
    Date: June 18, 2015.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 4234, MSC 9550, Bethesda, MD 02892, 301-443-9511, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Integration of Infectious Diseases and Substance 
Abuse Intervention Services for Individuals Living with HIV (R01).
    Date: July 7, 2015.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
4238, MSC 9550, Bethesda, MD 20892, 301-402-6020, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)


    Dated: May 7, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-11477 Filed 5-12-15; 8:45 am]
 BILLING CODE 4140-01-P

27332 Federal Register / Vol. 80, No. 92 / Wednesday, May 13, 2015 / Notices Place: Renaissance Washington, DC, 93.333, Clinical Research, 93.306, 93.333, 6001 Executive Boulevard, Suite 3208, MSC Dupont Circle, 1143 New Hampshire Avenue 93.337, 93.393–93.396, 93.837–93.844, 9529, Bethesda, MD 20892–9529, 301–435– NW., Washington, DC 20037. 93.846–93.878, 93.892, 93.893, National 6033, rajarams@mail.nih.gov. Contact Person: Nitsa Rosenzweig, Ph.D., Institutes of Health, HHS) (Catalogue of Federal Domestic Assistance Scientific Review Officer, Center for Program Nos. 93.853, Clinical Research Dated: May 8, 2015. Scientific Review, National Institutes of Related to Neurological Disorders; 93.854, Health, 6701 Rockledge Drive, Room 4152, David Clary, Biological Basis Research in the MSC 7760, Bethesda, MD 20892, (301) 404– Program Analyst, Office of Federal Advisory Neurosciences, National Institutes of Health, 7419, rosenzweign@csr.nih.gov. Committee Policy. HHS) Name of Committee: Digestive, Kidney and [FR Doc. 2015–11561 Filed 5–12–15; 8:45 am] Dated: May 7, 2015. Urological Systems Integrated Review Group; BILLING CODE 4140–01–P Kidney Molecular Biology and Genitourinary Carolyn Baum, Organ Development. Program Analyst, Office of Federal Advisory Date: June 9, 2015. Committee Policy. DEPARTMENT OF HEALTH AND Time: 8:00 a.m. to 6:00 p.m. [FR Doc. 2015–11464 Filed 5–12–15; 8:45 am] Agenda: To review and evaluate grant HUMAN SERVICES BILLING CODE 4140–01–P applications. Place: Kinzie Hotel, 20 West Kinzie Street, National Institutes of Health Chicago, IL 60654. Contact Person: Ryan G. Morris, Ph.D., National Institute of Neurological DEPARTMENT OF HEALTH AND Scientific Review Officer, Center for Disorders and Stroke; Notice of Closed HUMAN SERVICES Scientific Review, National Institutes of Meetings Health, 6701 Rockledge Drive, Room 4205, National Institutes of Health MSC 7814, Bethesda, MD 20892, 301–435– Pursuant to section 10(d) of the 1501, morrisr@csr.nih.gov. Federal Advisory Committee Act, as National Institute on Drug Abuse; Name of Committee: Integrative, amended (5 U.S.C. App.), notice is Notice of Closed Meetings Functional and Cognitive Neuroscience hereby given of the following meetings. Integrated Review Group; Somatosensory and The meetings will be closed to the Pursuant to section 10(d) of the Chemosensory Systems Study Section. public in accordance with the Federal Advisory Committee Act, as Date: June 9–10, 2015. provisions set forth in sections amended (5 U.S.C. App), notice is Time: 8:00 a.m. to 4:00 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., hereby given of the following meetings. Agenda: To review and evaluate grant as amended. The grant applications and The meetings will be closed to the applications. public in accordance with the Place: Washington Plaza Hotel, 10 Thomas the discussions could disclose confidential trade secrets or commercial provisions set forth in sections Circle NW., Washington, DC 20005. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: M. Catherine Bennett, property such as patentable material, Ph.D., Scientific Review Officer, Center for and personal information concerning as amended. The grant applications and Scientific Review, National Institutes of individuals associated with the grant the discussions could disclose Health, 6701 Rockledge Drive, Room 5182, applications, the disclosure of which confidential trade secrets or commercial MSC 7846, Bethesda, MD 20892, 301–435– would constitute a clearly unwarranted property such as patentable materials, 1766, bennettc3@csr.nih.gov. and personal information concerning invasion of personal privacy. Name of Committee: Biological Chemistry individuals associated with the grant and Macromolecular Biophysics Integrated Name of Committee: Neurological Sciences applications, the disclosure of which Review Group; Macromolecular Structure Training Initial Review Group NST–1 Subcommittee. would constitute a clearly unwarranted and Function D Study Section. invasion of personal privacy. Date: June 9, 2015. Date: May 11–12, 2015. Time: 8:00 a.m. to 5:00 p.m. Time: 8:00 a.m. to 6:00 p.m. Name of Committee: National Institute on Agenda: To review and evaluate grant Agenda: To review and evaluate grant Drug Abuse Special Emphasis Panel NIH applications. applications. Pathway to Independence Award (K99/R00). Place: St. Gregory Hotel, 2033 M Street Place: The Westin St. Francis, 335 Powell Date: June 4, 2015. NW., Washington, DC 20036. Street, San Francisco, CA 94102. Time: 1:00 p.m. to 4:00 p.m. Contact Person: James W. Mack, Ph.D., Contact Person: Raul A. Saavedra, Ph.D., Agenda: To review and evaluate grant Scientific Review Officer, Center for Scientific Review Officer, Scientific Review applications. Scientific Review, National Institutes of Branch, Division of Extramural Research, Place: National Institutes of Health, Health, 6701 Rockledge Drive, Room 4154, NINDS/NIH/DHHS/Neuroscience Center, Neuroscience Center, 6001 Executive MSC 7806, Bethesda, MD 20892, (301) 435– 6001 Executive Boulevard, Suite 3208, MSC Boulevard, Rockville, MD 20852, (Telephone 2037, mackj2@csr.nih.gov. 9529, Bethesda, MD 20892–9529, 301–496– Conference Call). Name of Committee: Emerging 9223, saavedrr@ninds.nih.gov. Contact Person: Hiromi Ono, Ph.D., Technologies and Training Neurosciences This notice is being published less than 15 Scientific Review Officer, Office of Integrated Review Group; Neuroscience and days prior to the meeting due to the timing Extramural Affairs, National Institute on Ophthalmic Imaging Technologies Study limitations imposed by the review and Drug Abuse, National Institutes of Health, Section. funding cycle. DHHS, 6001 Executive Boulevard, Room Date: June 9–10, 2015. Name of Committee: National Institute of 4238, MSC 9550, Bethesda, MD 20892, 301– Time: 9:00 a.m. to 5:00 p.m. Neurological Disorders and Stroke Special 402–6020, hiromi.ono@nih.gov. Agenda: To review and evaluate grant Emphasis Panel, BRAIN: Technologies for Name of Committee: National Institute on applications. Large-Scale Recording. Drug Abuse Special Emphasis Panel NIH Place: Mayflower Park Hotel, 405 Olive Date: July 9–10, 2015. Summer Research Experience Programs asabaliauskas on DSK5VPTVN1PROD with NOTICES Way, Seattle, WA 98101. Time: 8:00 a.m. to 2:00 p.m. (R25). Contact Person: Yvonne Bennett, Ph.D., Agenda: To review and evaluate Date: June 4, 2015. Scientific Review Officer, Center for cooperative agreement applications. Time: 12:00 p.m. to 1:00 p.m. Scientific Review, National Institutes of Place: The Fairmont Washington, DC, 2401 Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 5199, M Street NW., Washington, DC 20037. applications. MSC 7846, Bethesda, MD 20892, 301–379– Contact Person: Shanta Rajaram, Ph.D., Place: National Institutes of Health, 3793, bennetty@csr.nih.gov. Scientific Review Officer, Scientific Review Neuroscience Center, 6001 Executive (Catalogue of Federal Domestic Assistance Branch, Division of Extramural Research, Boulevard, Rockville, MD 20852, (Telephone Program Nos. 93.306, Comparative Medicine; NINDS/NIH/DHHS/Neuroscience Center, Conference Call). VerDate Sep<11>2014 17:27 May 12, 2015 Jkt 235001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\13MYN1.SGM 13MYN1

Federal Register / Vol. 80, No. 92 / Wednesday, May 13, 2015 / Notices 27333 Contact Person: Hiromi Ono, Ph.D., provisions set forth in sections Place: Pier 2620 Hotel Fisherman’s Wharf, Scientific Review Officer, Office of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 2620 Jones Street, San Francisco, CA 94133. Extramural Affairs, National Institute on as amended. The grant applications and Contact Person: Lisa Steele, Ph.D., Drug Abuse, National Institutes of Health, Scientific Review Officer, Center for the discussions could disclose Scientific Review, National Institutes of DHHS, 6001 Executive Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, 301– confidential trade secrets or commercial Health, 6701 Rockledge Drive, Room 3139, 402–6020, hiromi.ono@nih.gov. property such as patentable material, MSC 7770, Bethesda, MD 20892, (301) 257– Name of Committee: National Institute on and personal information concerning 2638, steeleln@csr.nih.gov. Drug Abuse Special Emphasis Panel individuals associated with the grant Name of Committee: Oncology 2— Exploratory Studies of Smoking Cessation applications, the disclosure of which Translational Clinical Integrated Review Interventions for People with Schizophrenia would constitute a clearly unwarranted Group, Basic Mechanisms of Cancer (R21/R33). invasion of personal privacy. Therapeutics Study Section. Date: June 18, 2015. Date: June 8–9, 2015. Time: 12:00 p.m. to 4:00 p.m. Name of Committee: Center for Scientific Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant Review, Special Emphasis Panel, MD15–005, Agenda: To review and evaluate grant NIH, Big Data to Knowledge (BD2K) applications. applications. Enhancing Diversity in Biomedical Data Place: Ritz-Carlton Hotel at Pentagon City, Place: National Institutes of Health, Science. 1250 South Hayes Street, Arlington, VA Neuroscience Center, 6001 Executive Date: May 29, 2015. 22202. Boulevard, Rockville, MD 20852, (Telephone Time: 12:00 p.m. to 4:00 p.m. Contact Person: Lambratu Rahman Sesay, Conference Call). Agenda: To review and evaluate grant Ph.D., Scientific Review Officer, Center for Contact Person: Jagadeesh S. Rao, Ph.D., applications. Scientific Review, National Institutes of Scientific Review Officer, Office of Place: Center for Scientific Review, 6701 Health, 6701 Rockledge Drive, Room 6214, Extramural Affairs, National Institute on Rockledge Drive, Bethesda, MD 20814, Drug Abuse, National Institutes of Health, MSC 7804, Bethesda, MD 20892, 301–451– (Virtual Meeting). 3493, rahman-sesayl@csr.nih.gov. DHHS, 6001 Executive Boulevard, Room Contact Person: Delia Olufokunbi Sam, 4234, MSC 9550, Bethesda, MD 02892, 301– Name of Committee: Center for Scientific Ph.D., Scientific Review Officer, Center for Review Special Emphasis Panel; Small 443–9511, jrao@nida.nih.gov. Scientific Review, National Institutes of Name of Committee: National Institute on Business: Cancer Drug Development and Health, 6701 Rockledge Drive, Room 3158, Therapeutics. Drug Abuse Special Emphasis Panel MSC 7770, Bethesda, MD 20892, 301–435– Date: June 9–10, 2015. Integration of Infectious Diseases and 0684, olufokunbisamd@csr.nih.gov. Time: 10:00 a.m. to 4:00 p.m. Substance Abuse Intervention Services for This notice is being published less than 15 Agenda: To review and evaluate grant Individuals Living with HIV (R01). days prior to the meeting due to the urgent applications. Date: July 7, 2015. need to meet timing limitations imposed by Place: National Institutes of Health, 6701 Time: 12:00 p.m. to 5:00 p.m. the intramural research review cycle. Rockledge Drive, Bethesda, MD 20892, Agenda: To review and evaluate grant (Virtual Meeting). Name of Committee: Musculoskeletal, Oral applications. Contact Person: Lilia Topol, Ph.D., and Skin Sciences, Integrated Review Group Place: National Institutes of Health, Scientific Review Officer, Center for Musculoskeletal Tissue Engineering Study Neuroscience Center, 6001 Executive Scientific Review, National Institutes of Section. Boulevard, Rockville, MD 20852, (Telephone Health, 6701 Rockledge Drive, Room 6192, Date: June 1–2, 2015. Conference Call). MSC 7804, Bethesda, MD 20892, 301–451– Time: 8:00 a.m. to 5:30 p.m. Contact Person: Hiromi Ono, Ph.D., 0131, ltopol@mail.nih.gov. Agenda: To review and evaluate grant Scientific Review Officer, Office of applications. Name of Committee: Center for Scientific Extramural Affairs, National Institute on Place: Residence Inn Bethesda, 7335 Review Special Emphasis Panel, AREA: Drug Abuse, National Institutes of Health, Wisconsin Avenue, Bethesda, MD 20814. Oncological Sciences Grant Applications. DHHS, 6001 Executive Boulevard, Room Contact Person: Baljit S Moonga, Ph.D., Date: June 9, 2015. 4238, MSC 9550, Bethesda, MD 20892, 301– Scientific Review Officer, Center for Time: 11:00 a.m. to 3:00 p.m. 402–6020, hiromi.ono@nih.gov. Scientific Review, National Institutes of Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance Health, 6701 Rockledge Drive, Room 4214, applications. Program Nos.: 93.279, Drug Abuse and MSC 7806, Bethesda, MD 20892, 301–435– Place: National Institutes of Health, 6701 Addiction Research Programs, National 1777, moongabs@mail.nih.gov. Rockledge Drive, Bethesda, MD 20892, Institutes of Health, HHS) Name of Committee: Center for Scientific (Telephone Conference Call). Review, Special Emphasis Panel, Member Contact Person: Sally A Mulhern, Ph.D., Dated: May 7, 2015. Conflict: Alcohol. Scientific Review Officer, Center for Carolyn Baum, Date: June 2, 2015. Scientific Review, National Institutes of Program Analyst, Office of Federal Advisory Time: 8:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 6214, Committee Policy. Agenda: To review and evaluate grant MSC 7804, Bethesda, MD 20892, (301) 435– applications. 5877, mulherns@csr.nih.gov. [FR Doc. 2015–11477 Filed 5–12–15; 8:45 am] Place: National Institutes of Health, 6701 Name of Committee: Cardiovascular and BILLING CODE 4140–01–P Rockledge Drive, Bethesda, MD 20892, Respiratory Sciences Integrated Review (Virtual Meeting). Group, Cardiovascular Differentiation and Contact Person: Michael Selmanoff, Ph.D., Development Study Section. DEPARTMENT OF HEALTH AND Scientific Review Officer, Center for Date: June 10, 2015. HUMAN SERVICES Scientific Review, National Institutes of Time: 8:00 a.m. to 6:00 p.m. Health, 6701 Rockledge Drive, Room 5164, Agenda: To review and evaluate grant National Institutes of Health MSC 7844, Bethesda, MD 20892, 301–435– applications. 1119, selmanom@csr.nih.gov. Place: Hotel Monaco Alexandria, 480 King asabaliauskas on DSK5VPTVN1PROD with NOTICES Center for Scientific Review; Notice of Name of Committee: Population Sciences Street, Alexandria, VA 22314. Closed Meetings and Epidemiology Integrated Review Group, Contact Person: Sara Ahlgren, Ph.D., Infectious Diseases, Reproductive Health, Scientific Review Officer, Center for Pursuant to section 10(d) of the Asthma and Pulmonary Conditions, Study Scientific Review, National Institutes of Federal Advisory Committee Act, as Section. Health, 6701 Rockledge Drive, RM 4136, amended (5 U.S.C. App.), notice is Date: June 4–5, 2015. Bethesda, MD 20817–7814, 301–435–0904, hereby given of the following meetings. Time: 8:00 a.m. to 2:00 p.m. sara.ahlgren@nih.gov. The meetings will be closed to the Agenda: To review and evaluate grant Name of Committee: Endocrinology, public in accordance with the applications. Metabolism, Nutrition and Reproductive VerDate Sep<11>2014 17:27 May 12, 2015 Jkt 235001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\13MYN1.SGM 13MYN1


Document Created: 2015-12-16 07:47:15
Document Modified: 2015-12-16 07:47:15
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJune 4, 2015.
FR Citation80 FR 27332 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR